These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 17183313)

  • 1. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.
    Noguera-Troise I; Daly C; Papadopoulos NJ; Coetzee S; Boland P; Gale NW; Lin HC; Yancopoulos GD; Thurston G
    Nature; 2006 Dec; 444(7122):1032-7. PubMed ID: 17183313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.
    Noguera-Troise I; Daly C; Papadopoulos NJ; Coetzee S; Boland P; Gale NW; Lin HC; Yancopoulos GD; Thurston G
    Novartis Found Symp; 2007; 283():106-20; discussion 121-5, 238-41. PubMed ID: 18300417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis.
    Ridgway J; Zhang G; Wu Y; Stawicki S; Liang WC; Chanthery Y; Kowalski J; Watts RJ; Callahan C; Kasman I; Singh M; Chien M; Tan C; Hongo JA; de Sauvage F; Plowman G; Yan M
    Nature; 2006 Dec; 444(7122):1083-7. PubMed ID: 17183323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting.
    Lobov IB; Renard RA; Papadopoulos N; Gale NW; Thurston G; Yancopoulos GD; Wiegand SJ
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3219-24. PubMed ID: 17296940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta-like 4/Notch signaling and its therapeutic implications.
    Yan M; Plowman GD
    Clin Cancer Res; 2007 Dec; 13(24):7243-6. PubMed ID: 18094402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
    Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL
    Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis.
    Oon CE; Harris AL
    Biochem Soc Trans; 2011 Dec; 39(6):1612-8. PubMed ID: 22103496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
    Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL
    Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.
    Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E
    Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth.
    Thurston G; Noguera-Troise I; Yancopoulos GD
    Nat Rev Cancer; 2007 May; 7(5):327-31. PubMed ID: 17457300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function.
    Patel NS; Li JL; Generali D; Poulsom R; Cranston DW; Harris AL
    Cancer Res; 2005 Oct; 65(19):8690-7. PubMed ID: 16204037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Dll4 therapy: can we block tumour growth by increasing angiogenesis?
    Sainson RC; Harris AL
    Trends Mol Med; 2007 Sep; 13(9):389-95. PubMed ID: 17822956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis.
    Hellström M; Phng LK; Hofmann JJ; Wallgard E; Coultas L; Lindblom P; Alva J; Nilsson AK; Karlsson L; Gaiano N; Yoon K; Rossant J; Iruela-Arispe ML; Kalén M; Gerhardt H; Betsholtz C
    Nature; 2007 Feb; 445(7129):776-80. PubMed ID: 17259973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching.
    Suchting S; Freitas C; le Noble F; Benedito R; Bréant C; Duarte A; Eichmann A
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3225-30. PubMed ID: 17296941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications.
    Li JL; Harris AL
    Front Biosci (Landmark Ed); 2009 Jan; 14(8):3094-110. PubMed ID: 19273260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bv8 regulates myeloid-cell-dependent tumour angiogenesis.
    Shojaei F; Wu X; Zhong C; Yu L; Liang XH; Yao J; Blanchard D; Bais C; Peale FV; van Bruggen N; Ho C; Ross J; Tan M; Carano RA; Meng YG; Ferrara N
    Nature; 2007 Dec; 450(7171):825-31. PubMed ID: 18064003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition.
    Dang DT; Chun SY; Burkitt K; Abe M; Chen S; Havre P; Mabjeesh NJ; Heath EI; Vogelzang NJ; Cruz-Correa M; Blayney DW; Ensminger WD; St Croix B; Dang NH; Dang LH
    Cancer Res; 2008 Mar; 68(6):1872-80. PubMed ID: 18339868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer.
    Patel NS; Dobbie MS; Rochester M; Steers G; Poulsom R; Le Monnier K; Cranston DW; Li JL; Harris AL
    Clin Cancer Res; 2006 Aug; 12(16):4836-44. PubMed ID: 16914569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis.
    Affara NI; Robertson FM
    In Vivo; 2004; 18(5):525-42. PubMed ID: 15523889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts.
    Miles KM; Seshadri M; Ciamporcero E; Adelaiye R; Gillard B; Sotomayor P; Attwood K; Shen L; Conroy D; Kuhnert F; Lalani AS; Thurston G; Pili R
    PLoS One; 2014; 9(11):e112371. PubMed ID: 25393540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.